Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin.
about
Effects of 12 weeks of treatment with intravenously administered bococizumab, a humanized monoclonal antibody blocking proprotein convertase subtilisin/kexin type 9, in hypercholesterolemic subjects on high-dose statin.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@en
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@nl
type
label
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@en
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@nl
prefLabel
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@en
Effects of 12 weeks of treatme ...... subjects on high-dose statin.
@nl
P2093
P2860
P356
P1476
Effects of 12 weeks of treatme ...... c subjects on high-dose statin
@en
P2093
Charles M Baum
David G Robertson
Pamela D Garzone
Philippe Forgues
Sergio Fazio
Tenshang Joh
P2860
P356
10.1111/1755-5922.12308
P577
2017-11-25T00:00:00Z